When the model was adjusted for the benchmark biomarker NT‐proBNP, CERT2 was no longer independently related to CV‐death and it's relation with MACE was of borderline significance, while a strong association for Ln‐transformed NT‐proBNP could be observed: 1.95 (1.69–2.26) and 1.76 (1.55–2.00), respectively for CV death and MACE.
← all excerpts
Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.
1
—
—